Trade Mark Journal No.2025/026 27 June 2025
WO0000001859194 (42,44)
Office of origin: United States of America
Date of International Registration:28 April 2025
Date of designation in the UK:
28 April 2025
International priority date claimed: 29 October 2024
(United States of America)
(98825256)
- Class 42
- Medical and scientific research and information services; scientific laboratory services; medical research laboratory services; biological research laboratory services; providing laboratory research services; genetic sequencing and molecular testing for scientific research purposes; molecular testing and services, namely, clinical diagnostics, scientific research, and processing and analysis of molecular assays; providing scientific research information; providing medical testing services and information in the field of disease research and classification.
- Class 44
- Medical molecular testing, monitoring and reporting services; medical testing services; medical testing for diagnostic or treatment purposes; medical testing services relating to the diagnosis and treatment of disease; medical laboratory analysis services; medical analysis services for diagnostic and treatment purposes; genetic sequencing and molecular testing for medical research, diagnostic and treatment purposes; providing information about molecular testing for medical purposes; consulting services in the fields of medical testing; medical diagnostic testing, monitoring and reporting services; medical diagnostic testing services in the field of human disease and human medical conditions; molecular diagnostic testing, monitoring and reporting services for medical purposes and medical research purposes.
Parse Biosciences, Inc.
Representative: Brendan J. Hughes Cooley LLP, 1299 Pennsylvania Avenue NW, Suite 700, Washington DC 20004, UNITED STATES OF AMERICA